PCSK9: From promise to clinical practice
EAS Academy. Lambert G. 03/24/17; 175475 Topic: Therapy
Disclosure(s): Research funding and honoraria from Pfizer, Amgen, and Sanofi-Regeneron
Prof. Gilles Lambert
Prof. Gilles Lambert

This course is exclusively accessible to users who attended the course in Taipei.

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies